Treating Basal Cell Carcinoma

Israel’s MediWound (see here previously) announced positive data from its Phase I/II study of MW005 for non-surgical treatment of Basal Cell Carcinoma (BCC) – a form of slow-growing skin cancer.  MW005 is safe, well-tolerated and completely cleared the BCC lesions.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *